PGR and endometrioid adenocarcinoma: However, the negative immunoreactivity for estrogen and progesterone receptors and carcinoembryonic antigen are considered crucial features that could distinguish the mesonephric carcinoma from differential diagnosis, particularly, endometrioid adenocarcinoma [1, 4, 5].